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The study by Xu et al., reported in this issue of the Archives of Med-
ical Science, is a large original study on breast cancer risk factors in Chi-
na, a country with low breast cancer incidence [1, 2]. The study shows
results from the project of breast cancer prediction (BCPC) in China, aim-
ing to screen breast cancer risk factors among Chinese women and pre-
dict individual risk of breast cancer through established risk factors. It
is a multicentric hospital-based case-control study, carried out in 14 hos-
pitals in 8 provinces of China, and, from January to July 2008, recruited
416 women aged 30 to 65 years with incident breast cancer and 1156 he  -
al  thy women.
We are not commenting upon stress anticipation, which goes beyond
our area of expertise. Apart from this, results from the BCPC study are
only partly in agreement with those from studies from Western Countries,
thus suggesting a somewhat different pattern of risk factors for the Chi-
nese population.
In particular, the study confirms the role of history of benign breast
disease biopsy in breast cancer [2], estimating an adjusted odds ratio (OR)
of 1.68 (95% confidence interval – CI – 1.19-2.38). 
Moreover, in agreement with most literature on breast cancer and fam-
ily history of breast cancer [3-6], the BCPC study found a positive, though
not significant, association between having a first degree-relative affect-
ed by breast cancer and the risk of breast cancer (OR = 1.66, 95% CI: 
0.77-3.59).
Reproductive and hormonal factors play a central role in the etiology
of breast cancer [7]. Earlier menarche and later menopause are well estab-
lished risk factors for the development of breast cancer [8-10], being
responsible for a prolonged lifetime exposure to endogenous hormones
[11]. The risk of breast cancer decreases by about 5% with each 1-year
delay in menarche [11-14] and, on average, the risk increases by about 2.7%
for each year menopause is delayed [13]. The positive association between
age at menarche and breast cancer risk found by Xu et al., with an OR of
1.41 (95% CI: 1.07-1.87) for women with menarche at age 14 years or more,
is inconsistent with the overall evidence. The increased risk associated to
menopause was also controversial, given the similar mean age at
menopause among cases and controls (i.e., 48.89 vs. 49.33 years, respec-
tively). Likewise, the Japan Collaborative Cohort Study, prospectively exam-
ining more than 38,000 women in a traditionally low-risk population as Japan,
found no association between breast cancer and age at menarche and at
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menopause [8]. Still, accurate adjustment for age
and socioeconomic factors is required for any infer-
ence on these factors.
In the BCPC study, parous women represent
almost the totality of cases and controls, and par-
ity tended to be uniformly low. Likewise, the appar-
ent uniformity of age at first birth may explain the
limited association with this well recognized risk
factor [15-17]. No meaningful differences emerged
between women with and without breast cancer in
terms of number of live births and age at first live
birth. Conversely, epidemiological literature consis-
tently found that a younger age at first full-term
pregnancy is associated to a lower lifetime risk of
breast cancer, and that a higher number of births
is related to a lower risk [2].
A protective effect of lactation on breast cancer
has been reported by several studies [3], including
the pooled analysis by the Endogenous Hormones
and Breast Cancer Collaborative Group, which found
that lifetime duration of breastfeeding was associ-
ated to a significant reduction in breast cancer risk
among parous women, with a relative risk (RR)
decreasing by 4.3% for every 12 months of breast-
feeding [18]. Data in the BCPC study are however
inadequate to materially contribute to the issue.
There is definite evidence that abortions are
unrelated to excess risk of breast cancer [19, 20].
A recent pooled analysis of 53 studies carried out
in 16 countries found no association between spon-
taneous abortion and breast cancer, but a moder-
ate protection for induced abortion [20]. However,
when the analysis was restricted to studies with
a prospective design, the risk of breast cancer did
not differ significantly according to the number or
timing of either type of abortion. The null associa-
tion reported by Xu et al. is therefore in line with
the most recent literature.
Evidence on the association between oral con-
traceptive (OC) use and breast cancer indicates
a modest increased risk, however restricted to cur-
rent or recent use, or the absence of any associa-
tion after 5 years or more since stopping [21-24].
Moreover, consistent findings from observational
studies and randomized trials showed an increased
breast cancer risk among women using combined
estrogen–progestogen therapy in meno  pause 
[25-27]. The risk increases with increasing du  ration
of use but decreases after cessation, leveling off
after 5 years since stopping postmenopausal hor-
mone use [25]. Crude results by Xu et al. were
apparently in line with the overall evidence, with
about 5.6% of cases and 3.9% of controls report-
ing OC use, and about 5.4% of cases and 2.5% of
controls reporting hormone replacement therapy
use; however the data were inadequate to perform
detailed analyses of such relations by duration and
timing of exposure, including time since stopping,
which is the key factor for these variables.
The BCPC study found an excess risk of breast
cancer among overweight/obese subjects. After
adjustment for selected risk factors, including
menopausal status, the OR for body mass index
(BMI) ≥ 24 kg/m2 as compared to BMI < 24 kg/m2
was 4.07 (95% CI: 2.98-5.55). It is well known that
the relation between BMI and breast cancer
depends on menopausal status, with an inverse
association among premenopausal women [3, 28-30],
likely due to a more frequent anovulation in obese
[31-33], and a moderate direct association among
postmenopausal women [34]. Body mass index
increases postmenopausal breast cancer risk main-
ly through elevated levels of circulating estrogens,
particularly estradiol, in overweight women [34].
After menopause, adipose tissue is the major source
of estrogen; moreover, overweight women have low
levels of sex-hormone-binding globulin, resulting
in a higher level of bio-available estrogens [34, 35].
Xu et al. investigated the association between BMI
and breast cancer with no distinction between pre
and postmenopausal status; thus the estimated OR
for overweight women may underestimate the real
association in postmenopausal women. Nonethe-
less, Xu et al. found an increased OR of about 4-fold
for BMI ≥ 24 kg/m2, somewhat higher than expect-
ed on the basis of accumulated evidence on such
relation in postmenopausal women [2, 3, 34-36]. In
a pooled analysis of three Italian case-control stud-
ies, including a total of 3108 postmenopausal breast
cancer patients and 2604 controls, ORs for succes-
sive BMI quintiles ranged from 1.2 to 1.4, as com-
pared to the lowest quintile, and the association
was stronger among elderly women [36]. A pooled
analysis from the Endogenous Hormones and
Breast Cancer Collaborative Group, including data
from eight prospective studies of postmenopausal
women, for a total of 624 case subjects and 1669
control subjects, found ORs of 1.17, 1.50, 1.78, and
1.50 for successive categories of BMI, as compared
to BMI < 22.5 kg/m2 [35]. It has been suggested
that the relation between weight and risk of breast
cancer in low risk areas, as China, may be different
from that observed in Western countries, with
a lack of association for premenopausal breast can-
cer and a stronger association for postmenopausal
breast cancer [2, 37]. Results from the BCPC study
are in agreement with this hypothesis, and suggest
a substantial excess risk for overweight women in
a population with a low prevalence of overweight
and among relatively young women (mean age was
around 46 years for both cases and controls).  Not
surprisingly, therefore, the RR appears to be par-
ticularly elevated in overweight women, though the
absolute risk and the population attributable risk
[38] are not necessarily greater in Chinese than in
Western populations.  Arch Med Sci 2, April / 2012 181
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Alcohol intake is the most consistent dietary fac-
tor related to breast cancer [39-41]. Heavy alcohol
intake, defined as the consumption of 3 or more
drinks/day, was found to be associated with an
increased risk of breast cancer by 40-50% [40]. For
light drinking (≤ 1 drink/day), a significant increase
risk of the order of 4% has been estimated from
a meta-analysis updated to November 2011 and
based on 113 studies [40]. From individual data from
53 epidemiological studies of breast cancer, the Col-
laborative Group on Hormonal Factors in Breast
Cancer found that, compared with non drinker
women, the RR of breast cancer was 1.32 (95% CI:
1.19-1.45) for women drinking 35-44 g of alco-
hol/day, and 1.46 (95% CI: 1.33-1.61) for those drink-
ing ≥ 45 g/day, with a RR of breast cancer increas-
ing by about 7% for each additional 10 g/day of
alcohol intake [41]. Conversely, a recent case-con-
trol study conducted in China on more than 1000
incident breast cancer cases found an inverse asso-
ciation with low-to-moderate alcohol intake [42].
Xu et al. reported a null association between alco-
hol drinking and breast cancer risk, although the
low prevalence of women who reported to drink
alcohol in the BCPC study (about 9% of both cases
and controls) do not allow to explore the relation
in detail.
The possible effect of smoking on breast cancer
risk has been investigated in a large number of
studies [41]. Globally, data provided evidence that
cigarette smoking is not associated with an appre-
ciably increased breast cancer risk, as also emerged
in the BCPC study. 
One of the limits of the study by Xu and et al. is
the lack of information on hormone receptor sta-
tus. Recent epidemiological evidence suggests that
the etiology of hormone receptor defined breast
cancers may be heterogeneous [43-45]. In a recent
systematic review collecting information on 31 stud-
ies, delayed childbearing and nulliparity were asso-
ciated with increased risk of developing estrogen
receptor (ER)+ breast cancers but not ER– breast
cancers, whereas early age at menarche and post-
menopausal obesity were more consistently asso-
ciated with increased risk of hormone receptor-
positive than hormone receptor-negative tumors
[43]. In 2006, a meta-analysis focused on repro-
ductive factors found that the protective effect of
parity and early age at first birth was confined to
ER+/progesterone receptor (PR)+ cancers, while that
of late age at menarche was significant in both sub-
types of breast cancer, although stronger for
ER+/PR+ than ER–/PR– cancers [44]. On the other
hand, breastfeeding [43, 44], alcohol, smoking, fam-
ily history of breast cancer, and premenopausal obe-
sity [43] were similarly associated with both hor-
mone receptor-defined breast cancers. Although it
has been suggested that ER/PR status varies
among racial groups and results from these reviews
[43, 44] were derived from studies conducted pre-
dominantly on Western populations, comparable
findings were obtained by the Shanghai Breast Can-
cer Study [45]. In studies focused on breast cancer
as a single entity, as that by Xu et al., some asso-
ciations restricted to a breast cancer subtype could
be diluted or masked.
Still, the BCPC study is an important original con-
tribution towards our quantification of breast can-
cer risk factors.
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